ValOre Metals Corp. (TSXV:VO)

Elevation Oncology Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Net Income	-3.22	-2.59	24	-18.33	-5.64	-3.73
Depreciation & Amortization	0.02	0.02	0.07	0.07	0.05	0.04
Loss (Gain) From Sale of Investments	0.75	-	-	-	-	-
Stock-Based Compensation	-	0.1	0.4	1.54	-	0.38
Other Operating Activities	-0.37	0.01	-31.49	-0.44	0.92	0.04
Change in Accounts Receivable	-0	0	-0	-	0	0.01
Change in Accounts Payable	0.12	0.08	-0.11	0.86	-0.38	0.29
Change in Other Net Operating Assets	-0.43	-0.34	0.67	-0.72	-0.03	0.13
Operating Cash Flow	-3.14	-2.72	-6.46	-17.02	-5.08	-2.85
Capital Expenditures	-0.03	-	-	-	-0.08	-2
Investment in Securities	-	-	-	0.18	0.08	0.21
Other Investing Activities	-	-	3	-	-	-
Investing Cash Flow	-0.28	-	3	0.18	0.01	-1.79
Short-Term Debt Issued	-	-	0.52	0.6	0.95	1.27
Total Debt Issued	-0.64	-	0.52	0.6	0.95	1.27
Short-Term Debt Repaid	-	-	-0.02	-	-2.34	-
Total Debt Repaid	-	-	-0.02	-	-2.34	-
Net Debt Issued (Repaid)	-0.64	-	0.5	0.6	-1.39	1.27
Issuance of Common Stock	6.57	2.43	2.59	16.1	8.76	1.43
Other Financing Activities	-0.24	0.7	-0.01	-0.79	-0.31	-
Financing Cash Flow	5.69	3.13	3.08	15.91	7.05	2.7
Net Cash Flow	2.27	0.4	-0.38	-0.92	1.98	-1.93
Free Cash Flow	-3.17	-2.72	-6.46	-17.02	-5.15	-4.85
Free Cash Flow Per Share	-0.02	-0.02	-0.04	-0.12	-0.05	-0.06
Levered Free Cash Flow	-0.57	-1.22	-3.45	-9.43	-3.69	-5.32
Unlevered Free Cash Flow	-0.57	-1.22	-3.45	-9.43	-3.63	-5.29

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.